Hos psoriasis patienter resulterede behandling med infliximab i fald i epidermal inflammation og normalisering af keratinocytdifferenciering i psoriasis plaques.
In psoriasis patients, treatment with infliximab resulted in decreases in epidermal inflammation and normalization of keratinocyte differentiation in psoriatic plaques.